1. ABBV will attend TD Cowen's Health Care Conference on March 5, 2025. 2. Management will participate in a live fireside chat at 8:10 a.m. CT. 3. Audio webcast of the presentation will be available for investors. 4. ABBV focuses on innovative medicines for serious health issues. 5. Key therapeutic areas include immunology, oncology, neuroscience, and eye care.
While the conference offers visibility, it may not lead to immediate stock price changes. Past events showed limited long-term market impact despite high-profile presentations.
The conference is relevant for investor sentiment but lacks material financial implications. Analysts and investors may gauge management strategies but will likely await concrete data or developments.
The conference is imminent, but any resultant market impact typically unfolds quickly. Historical trends show such events often don’t drive long-lasting price changes.
AbbVie (NYSE: ABBV) will participate in the TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, 2025. Management will participate in a fireside chat at 8:10 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Gabby Tarbert
(224) 244-0111
email@example.com
Liz Shea
(847) 935-2211
email@example.com
SOURCE AbbVie